A detailed history of Chesapeake Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chesapeake Wealth Management holds 8,460 shares of BMY stock, worth $480,866. This represents 0.15% of its overall portfolio holdings.

Number of Shares
8,460
Previous 8,419 0.49%
Holding current value
$480,866
Previous $349,000 25.21%
% of portfolio
0.15%
Previous 0.13%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$39.66 - $51.75 $1,626 - $2,121
41 Added 0.49%
8,460 $437,000
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $312,863 - $411,891
-7,773 Reduced 48.01%
8,419 $349,000
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $178,101 - $201,932
-3,712 Reduced 18.65%
16,192 $878,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $39,608 - $47,263
-817 Reduced 3.94%
19,904 $1.02 Million
Q3 2023

Nov 16, 2023

SELL
$57.89 - $64.73 $30,218 - $33,789
-522 Reduced 2.46%
20,721 $1.2 Million
Q2 2023

Aug 01, 2023

BUY
$63.71 - $70.74 $11,276 - $12,520
177 Added 0.84%
21,243 $1.36 Million
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $68,601 - $77,809
1,044 Added 5.21%
21,066 $1.46 Million
Q4 2022

Feb 23, 2023

BUY
$68.48 - $81.09 $48,620 - $57,573
710 Added 3.68%
20,022 $1.44 Million
Q3 2022

Oct 28, 2022

BUY
$0.13 - $76.84 $682 - $403,486
5,251 Added 37.34%
19,312 $1.37 Million
Q2 2022

Jul 21, 2022

SELL
$72.62 - $79.98 $6,027 - $6,638
-83 Reduced 0.59%
14,061 $1.08 Million
Q1 2022

Apr 19, 2022

SELL
$61.48 - $73.72 $35,228 - $42,241
-573 Reduced 3.89%
14,144 $1.03 Million
Q4 2021

Feb 03, 2022

SELL
$53.63 - $62.52 $92,940 - $108,347
-1,733 Reduced 10.53%
14,717 $918,000
Q3 2021

Oct 26, 2021

SELL
$59.17 - $69.31 $192,243 - $225,188
-3,249 Reduced 16.49%
16,450 $973,000
Q2 2021

Jul 29, 2021

SELL
$61.91 - $67.42 $147,098 - $160,189
-2,376 Reduced 10.76%
19,699 $1.32 Million
Q1 2021

Apr 26, 2021

SELL
$59.34 - $66.74 $683,596 - $768,844
-11,520 Reduced 34.29%
22,075 $1.39 Million
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $137,017 - $155,265
2,373 Added 7.6%
33,595 $2.08 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $32,620 - $36,147
-568 Reduced 1.79%
31,222 $1.88 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $11,073 - $12,946
202 Added 0.64%
31,790 $1.87 Million
Q1 2020

Apr 29, 2020

BUY
$46.4 - $67.43 $40,971 - $59,540
883 Added 2.88%
31,588 $1.76 Million
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $553,760 - $722,330
11,253 Added 57.85%
30,705 $1.97 Million
Q3 2019

Oct 25, 2019

BUY
$42.77 - $50.71 $209,915 - $248,884
4,908 Added 33.75%
19,452 $986,000
Q2 2019

Aug 01, 2019

BUY
$44.62 - $49.34 $68,759 - $76,032
1,541 Added 11.85%
14,544 $660,000
Q1 2019

Apr 17, 2019

SELL
$45.12 - $53.8 $22,560 - $26,900
-500 Reduced 3.7%
13,003 $620,000
Q4 2018

Feb 06, 2019

SELL
$48.76 - $63.23 $27,305 - $35,408
-560 Reduced 3.98%
13,503 $702,000
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $29,968 - $33,801
-543 Reduced 3.72%
14,063 $873,000
Q2 2018

Aug 07, 2018

SELL
$50.53 - $62.98 $35,371 - $44,086
-700 Reduced 4.57%
14,606 $809,000
Q1 2018

Jun 04, 2018

BUY
$59.92 - $68.98 $917,135 - $1.06 Million
15,306 New
15,306 $968,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Chesapeake Wealth Management Portfolio

Follow Chesapeake Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Wealth Management with notifications on news.